Abstract Purpose: To formulate fast-disintegrating tablets (FDT) of rosuvastatin calcium (RST) using β-
INTRODUCTION
Approximately 40 % of newly developed drugs are poorly water soluble [1] . Poor solubility leads to poor dissolution in the gastrointestinal tract that results in variable oral absorption and bioavailability. Polymeric complexation can promote dissolution, absorption and ultimately bioavailability thereby reducing particle size or converting their nature from crystalline to amorphous [2 -4] . Different techniques have been utilized in literature for this purpose like inclusion complexes, solid dispersions, hydrogel microparticles, microemulsions, microparticles, fast dissolving tablets, prodrug, milling, cocrystals, cryogenic, spray drying etc. [5] [6] [7] .
Improved dissolution rate can be ascribed to (i) an increased solubility of the drug because of its amorphous state or small particle size (Kelvin's law) [8] (ii) an increasing surface area available for drug dissolution because of the small size of the drug particles [9] and (iii) an improved wetting of the drug caused by the hydrophilic carrier [10] .
Various superdisintegrants like kyron T134, crospovidone, pregelatinized starch, sodium starch glycolate, croscarmellose sodium etc., along with hydrophilic carriers such as β-cyclodextrin etc., are used to enhance solubility and consequently, patient compliance [11] [12] [13] [14] . Rosuvastatin calcium (RST), belongs to BCS class II drugs having low solubility and high permeability. It is poorly water-soluble 3-hydroxy-3-methyl glutaryl CoA (HMG-CoA) reductase inhibitor. This enzyme catalyzes the conversion of HMG-CoA to mevalonate, which is an early and rate-limiting step in cholesterol biosynthesis. It is a potent lipid-lower ingredient used as hypolipidemic agent [15] .
The objective of this study was to fabricate FDT's of rosuvastatin calcium using solid dispersion technique by polymer and disintegrants as well as their physical mixture.
EXPERIMENTAL Materials
Rosuvastatin was obtained as gift sample from Getz pharmaceuticals Islamabad, Pakistan. Methanol and β-cyclodextrin were purchased from Sigma Aldrich Chemie GmbH, Steinheim, Germany. Kyron T134, sodium starch glycolate and saccharine were obtained from Warrick pharmaceuticals Islamabad, Pakistan. Magnesium stearate and lactose were taken from chemical store of Department of Pharmacy, The Islamia University of Bahawalpur. All the chemicals used were relatively of high purity (97 -99 %).
Method
Three different approaches of FDT's formulations were adapted; (1) solid dispersions composed of drug and carrier in which superdisintegrants were incorporated, (2) solid dispersions composed of drug and carrier physically mixed with superdisintegrants and (3) physical mixtures of drug, carrier and superdisintegrants.
F1 -F15 were prepared by slight modification of already used method [13] . Solution of drug was prepared in methanol while β-cyclodextrin and superdisintegrants were dissolved in water. Predetermined amounts of drug, β-cyclodextrin and superdisintegrants were weighed on an electronic weighing balance and dissolved in respective solvents. Both solutions were sonicated until clear solution was formed. These solutions were mixed and placed on hot plate stirrer to evaporate the solvent. Prepared solid dispersions were freeze dried for 24 h in lyophilizer (Alpha 1-4 LD Germany). All of these formulations were compressed into FDT's using 8 mm round flat beveled edge punches on a 10 station rotary tableting machine. A total of 15 formulations were prepared by varying concentration of carrier and superdisintegrants using these three different approaches as shown in Table 1 [13] .
FTIR spectroscopy
FTIR spectra were obtained between 400 and 4000 cm -1 by using IR spectrophotometer (Bruker Tensar 27 Germany) to confirm complex formation. FTIR spectra of individual ingredients and tablets were taken [16] .
Thermal analysis
DSC and TGA analysis of prepared FDT's and all ingredients were taken to determine stability of ingredients in prepared tablets. DSC (Q600 TA USA) was done by heating samples from ambient to 400 °C at a heating rate of 10 °C/min under nitrogen atmosphere at a flow rate of 10 ml/min [16] . 
Friability
Friability of tablets was determined using Roche friabilator (Pharma Test, Germany). Twenty tablets were weighed and placed in the drum of the friabilator at a speed of 25 rpm. Tablets were allowed to revolve, fall from height of six inches for 4 min. Then tablets were de-dusted using muslin cloth and re-weighed. Then friability was measured by calculating % weight loss of 20 FDT's [16] .
Tablet disintegration
Tablet disintegration apparatus was used. Six tablets were taken and placed individually in tubes and properly covered. Temperature of medium was maintained at 37 ± 2 °C and timely monitored by thermometer. Time taken by the tablet to disintegrate completely was noted [16] .
Wetting time
A circular tissue paper having diameter 8 cm folded twice was placed in the petri dish. 10 ml of phosphate buffer solution of pH 6.80 used as saliva was taken in petri dish. Single tablet was placed on tissue paper and time for complete wetting was noted [17] .
Dissolution study
Dissolution studies of FDTs were performed using USP type-II apparatus. Speed of apparatus was set at 50 rpm, 900 ml of phosphate buffer solution of pH 6.80 was taken as dissolution medium in each vessel of the apparatus. A single tablet was placed in each vessel and temperature was kept at 37 ± 0.5 °C. Samples were removed from each vessel at regular intervals and was replaced by equal volume of freshly prepared media. Absorbance was measured by using UV/Vis spectrophotometer (UV 1700, Shimadzu, Japan) at 243 nm [18] .
In vitro dispersion time
About 6 ml phosphate buffer of pH 6.80 was taken in a beaker of 10 mL capacity. Tablet was placed in beaker and time required for complete dispersion of tablet was noted. Experiment was performed thrice for each formulation.
Water absorption ratio
Six milliliters of water was taken in a Petri dish of internal diameter 6.50 cm. A piece of tissue paper folded twice was placed in the petri dish. A tablet was weighed before placing onto tissue paper in petri dish and time taken by tablet for complete wetting was noted. Wetted tablet was reweighed and water absorption ratio was calculated [19] .
X-ray powder diffraction (XRPD)
Samples were analyzed using an X'Pert PROMPD diffractometer (PANalytical, Almelo, the Netherlands) with a copper anode (Cu Ka radiation, k = 0.15405 nm, 40 kV, 40 mA). The diffraction pattern was measured with a step size of 0.008 and a dwell time of 45 S at each step between 4 ° and 50 ° for 2 h at ambient temperature [20] .
Scanning electron microscopy
For SEM measurements to describe the shape and surface morphology as well as to check porosity on tablet surfaces that are helpful in rapid release of drug, rosuvastatin based FDT's were attached on metal stubs using doublesided adhesive tape, dried in a vacuum chamber, they were then sputter-coated with a gold layer of 10 nm thick and viewed under high resolution SEM (JSM-840, Joel Instruments, Tokyo, Japan) [21] .
Stability studies
The stability studies of FDT's were performed for three best formulations for a period of six months according to ICH (international conference on harmonization) guidelines. After period of 3 and 6 months tablets were re-evaluated for drug content and other parameters. Studies were performed under the following temperature and humidity conditions 37 ± 1 °C, 40 ± 1 °C, 50 ±1 °C and RH 75 ± 5 % [14] .
Statistical analysis

SPSS 18
® software was used to analyze the data. All results are expressed as mean ± standard deviation (SD). The data for various formulations were compared by one-way analysis of variance (ANOVA). P < 0.05 was considered to be statistically significant.
RESULTS
Powder for FDT's was first evaluated for rheological parameters. Results of these parameters were compared with pharmacopeial standards as shown in ( [15] . Thermal analysis was performed to check the stability of complexes formed between drug, carrier and superdisintegrants. DSC thermograms of rosuvastatin alone, physical mixture of drug, carrier and superdisintegrants as well as of prepared FDT's were also taken. There was present a sharp endothermic peak at 126 °C in DSC thermogram of pure drug and of physical mixture as well. (Fig 3) . Morphology of FDT's was determined by using scanning electron microscopy. SEM images had shown that pores had been created on surface of tablets (Fig 4) . Pores have favored influx of water inside of tablets to fasten the release of drug from the tablets and ultimately solubility was enhanced. Similar findings were observed by Inayat et al [21] .
Results of weight variation hardness, thickness, Friability, disintegration time and wetting time for all formulations were present within pharmacopeial limits as shown in Table 2 . Formulations based on solid dispersions exhibited better hardness results as compared to physical mixture [23] . Friability of all the formulations was less than 0.8 % which suggested that tablets had good mechanical strength. Statistically results of friability were tested by using one way ANOVA. Results of ANOVA between the groups show pvalue of 0.025 which was less than 0.05 indicating significance. Disintegration time for FDT's generally considered good if it is < 1 min (Table 3 ) [14] . Rapid uptake of water can cause swelling which ultimately produce bursting effect. This results in fast release of drug into the surrounding environment and hence solubility of loaded drug was enhanced. Similar to wetting time it was also lowest for F4 formulation [24] .
All formulations were evaluated for in vitro dispersion time and it was found lowest (23 s) for F4. Dispersion time was graded like FDT's containing solid dispersion of drug, carrier and disintegrant > FDT's containing solid dispersion of drug and carrier physically mixed with disintegrant > FDT's containing physical mixture of drug, carrier and disintegrant as shown in Table 4 . P-value was 0.018 for dispersion time.
Formulation F4 absorbed water approximately double its original weight as shown in Table 4 (p = 0.011), which indicates that the concentration of β-cyclodextrin and disintegrants affected tablet disintegration.
Dissolution studies have shown a marked difference in release of rosuvastatin from the commercially available tablets and FDT's. Maximum concentration of drug was released from FDT's within 15 min as compared to commercially available tablets. There was maximum release of drug in formulation F4 that was 99 % in 15 min (Fig 5) . (Fig 1) . Similar peaks were present in physical mixture of drug, superdisintegrants and β-cyclodextrin. It confirmed that, no interaction was present between drug and excipients. But FTIR spectra of our formulations had shown that characteristic peak of rosuvastatin was shifted from 3337.90 to 3127.13 cm -1 and complete absence of characteristic peak that was present at 1435.48 cm -1 due to O-H bending. These findings had supported that there was complex formation between drug and polymer in solid dispersions. Our results were in compliance of study conducted by Pavan et al [25] .
DSC studies depicts no interaction between drug and polymer. In thermogram of FDT's characteristic peak of rosuvastatin disappeared from 126 °C and shifted to higher temperature of 170 °C (Fig 2) . This shifting of peaks was due to the formation of solid complex between drug, carrier and superdisintegrants. Mura et al also found in their studies that disappearance or shifting of peaks confirmed that formation of complex [26] .
Hardness generally indicates that tablets are able to bear stress during handling, storage and transportation. A linear relationship exists between tablet hardness and disintegration time (DT). The absence of characteristics peaks in PXRD formulation indicated that drug had converted from crystalline to amorphous form. As a result solubility of rosuvastatin was enhanced in FDT's prepared by using β-cyclodextrin and superdisintegrants because amorphous forms are more soluble as compared to crystalline form. Similar results were obtained by Pavan et al in their study [25] .
Overall values of drug release were present between 93-99 % that were far better than commercially available tablets. These may also be due to increase in pores on surface of tablets as shown in SEM image (Fig 4) [27] . Based on the findings of dissolution studies, SEM, FTIR, DSC, PXRD of various formulations we found that β-cyclodextrin had influenced solubility of rosuvastatin used as model drug in this study. As a result in vitro dissolution was enhanced. When dissolution results of various formulations were compared based on method of preparation then it was found that FDT's containing solid dispersions had better release rate than FDT's containing physical mixture of same concentration of all constituents. Similar findings were obtained by Manjil et al [28] .
CONCLUSION
Rosuvastatin calcium FDTs were successfully prepared in this study for enhanced solubility of the drug. The techniques used should also be suitable for enhancement of the dissolution profile of other poorly water-soluble drugs.
